INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

78,781 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$31K
500 sh
Apr 21, 2026Apr 22, 2026
Page 1130 of 1970
← PrevNext →
traded Apr 21, 2026
+1d
SEC Form 4

Evidence

13
WA
Wilbur Maria Cristina AlapagDirector
AMRZAmrize Ltd
Tax withholding
F$11K
190 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

13
SR
Sisson George R IIIDirector
CFFIC & F FINANCIAL CORP
Grant or award
A—
450 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

13
KR
Kelley Elizabeth RDirector
CFFIC & F FINANCIAL CORP
Grant or award
A—
450 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
ON
Olmstead NathanSVP and CFO
PENGPenguin Solutions, Inc.
Tax withholding
F$70K
2,605 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
PM
Pelkowski Julie MarieEVP & CFO
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$3,044
12 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CC
Cook CodyExecutive Vice President
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,867
7 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
NL
Novacek Jorie LSVP, Controller
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,151
5 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
7,714 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
SS
Shine SarahExecutive Vice President
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$3,917
15 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$184K
5,000 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
NG
Necastro Timothy GPresident & CEO
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$19K
74 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
9,463 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
SP
Srinivasa ParthasarathyEVP, Chief Information Officer
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$2,812
11 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
DS
Dugan SeanExecutive Vice President
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,456
6 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$177K
5,235 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

11
DN
Debbi NirDirector, President
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$273
8 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

11
HJ
Hogan Michael JamesChief Business Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$30K
500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

10
FA
Fang AndyDirector
DASHDoorDash, Inc.
Grant or award
A—
11.2K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

10
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
738 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC Form 4

Evidence

10
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WC
Whitman Margaret CDirector
CRWVCoreWeave, Inc.
Grant or award
A$7,829
67 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
RH
Resch Martin H.President & CEO
CASSCASS INFORMATION SYSTEMS INC
Tax withholding
F$40K
830 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
RH
Resch Martin H.President & CEO
CASSCASS INFORMATION SYSTEMS INC
Grant or award
A—
1,975 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MV
Misra VishalDirector
PCORPROCORE TECHNOLOGIES, INC.
Grant or award
A—
10.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
SB
Shardelow Bianca B.VP, Controller & CAO
CXTCrane NXT, Co.
Tax withholding
F$8,445
182 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
SH
Schwartz Sanford HaroldDirector
RIVNRivian Automotive, Inc. / DE
Grant or award
A—
1,255 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
4,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
45.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
5,500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WD
Williams Stephen D.Director
HCCWARRIOR MET COAL, INC.
Grant or award
A—
1,423 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
80.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JE
Jones Mark E. Jr.President & COO, 10% Owner, Member of 10% owner group
GSHDGoosehead Insurance, Inc.
Grant or award
A—
50.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
4,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
5,500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence